The utility of sTREM-1 and Presepsin to Predict infection in Pediatric Patients Receiving Mechanical Circulatory Support
Presepsin and Procalcitonin decreased in advance of the development of a new infection in the MCS patient population, a direction of change different than expected. These findings highlight the importance of biomarker studies specifically performed in the MCS patient population, and the potential lack of translatability of biomarkers in other patient populations to the MCS patient population.
Authors
- Robin Alexander
- Brian R. Beckman (ORCID: https://orcid.org/0000-0003-4930-2707)
- Md Rejuan Haque (ORCID: https://orcid.org/0000-0002-0582-5269)
- Jianli Bi (ORCID: https://orcid.org/0000-0003-0935-7500)
- Robert Murray (ORCID: https://orcid.org/0000-0002-2383-1742)
- Andrew R. Yates (ORCID: https://orcid.org/0000-0003-2860-6808)
- Ruth Seabrook (ORCID: https://orcid.org/0000-0002-0352-2651)
- W. Joshua Frazier
Institutions
- Nationwide Children's Hospital (US)
Publication Details
- Journal
- Journal of ExtraCorporeal Technology
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1051/ject/2025008
- Primary Topic
- Neonatal and Maternal Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00